Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects-Reference-Cited by-同舟云学术

Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects

Published:2021-07-09 Issue:1 Volume:11 Page:100-111
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Abbas Richat¹,Riley Steve²,Nepal Sunil³,Bachinsky Mary²,Lee Kimberly C.²,Chappell Phillip B.²,Damle Bharat⁴

Affiliation:

1. Medical Product Evaluation Upjohn, Pfizer Inc. Collegeville Pennsylvania USA

2. Global Product Development Pfizer Inc. Groton Connecticut USA

3. SKN Statistical Consulting Services LLC Schwenksville Pennsylvania USA

4. Global Research and Development Pfizer Inc. New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.989

Reference20 articles.

1. Drugs@FDA: FDA‐Approved Drugs.https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020699. Accessed May 3 2021.

2. Venlafaxine

3. Venlafaxine Extended-Release

4. Clinical aspects of ventricular arrhythmias associated with QT prolongation

5. Drug‐induced QT prolongation and sudden death;Del Rosario ME;Mol Med,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Venlafaxine Intoxication is Required, Epileptic Seizures Alone Prolong QRS and QTC;The Journal of Emergency Medicine;2024-05

2. The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview;The Lancet Oncology;2022-09